Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.3 |